budipine
This page covers all budipine drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Potassium voltage-gated channel subfamily H member 2, Glutamate [NMDA] receptor.
Targets
Potassium voltage-gated channel subfamily H member 2, Glutamate [NMDA] receptor
Phase 2 pipeline (1)
- BUDIPINE · Neuroscience
Budipine works by blocking potassium channels in the brain, which can help regulate abnormal electrical activity.
Patent intelligence
- budipine patent landscape — aggregated cliff calendar, attackable patents, originator estates